Small Fiber Neuropathy Clinical Trials 2023

What are the top hospitals conducting small fiber neuropathy research?

When it comes to cutting-edge clinical trials focused on small fiber neuropathy, several hospitals across the United States are leading the way. In Baltimore, Johns Hopkins Bayview Medical Center is at the forefront of this research with one active trial dedicated to understanding and treating this condition. This prestigious institution recorded its first small fiber neuropathy trial in 2023, emphasizing their commitment to exploring new avenues for patients affected by this disorder. Similarly, Northwest Community Healthcare in Arlington Heights has also initiated a trial on small fiber neuropathy in 2023, recognizing the importance of advancing knowledge and treatment options for those experiencing this often-painful condition.

In Detroit's Henry Ford Health system has embarked upon resolute path acknowledging significance of addressing small-fiber-neuropathic symptoms through such studies.Its enrolling participants within their ongoing study about assessing efficacy involving potential interventions targeting Small Fiber Neuropathy;Their interest signifies how crucial knowing more about these aspects can be so that they might alleviate further complications linked closely towards effects exerted from decreased nerve function using evidence-based approaches. Meanwhile, PNA Center for Neurological Research stands out amongst others as a specialized center entirely devoted to neurological disorders in Phoenix.While they have only one ongoing clinical assessment into tackling ssmall-fiberneuropathies since last year without any previous records mentioned in all-time lists till now,yet it still showcases proactive efforts extended by institutions aiming primarily at unraveling mysteries behind disease mechanisms relating precisely towards peripheral nerves functioning throughout our bodies.This remarkable dedication ensures comprehensive exploration regardless if resultant data might not materialize yet,but it opens up unprecedented opportunities promising hope among sufferers while striving relentlessly until an effective breakthrough can be made

Which are the best cities for small fiber neuropathy clinical trials?

When it comes to small fiber neuropathy clinical trials, several cities offer opportunities for participation. Baltimore, Maryland; Arlington Heights, Illinois; Detroit, Michigan; and Phoenix, Arizona are among the top cities with one active trial each. These trials investigate various interventions such as skin biopsy in Baltimore and Panzyga IVIG in both Arlington Heights and Detroit. Additionally, the trial in Phoenix focuses on Fycompa alongside other potential treatments for small fiber neuropathy. With ongoing research taking place across these locations, individuals affected by this condition have options to explore new therapies and contribute to advancements in understanding and managing small fiber neuropathy.

Which are the top treatments for small fiber neuropathy being explored in clinical trials?

Clinical trials for small fiber neuropathy have identified two promising treatments in the spotlight. Skin biopsy, with one active trial and a total of three trials dedicated to small fiber neuropathy since 2016, holds promise as a diagnostic tool. Another potential treatment is Panzyga IVIG, currently being explored in one active trial specifically for small fiber neuropathy since its listing in 2023. These advancements bring hope for improved understanding and management of this debilitating condition.

What are the most recent clinical trials for small fiber neuropathy?

Small fiber neuropathy, a condition characterized by damage to the small nerve fibers, has seen recent advancements in clinical trials. One notable trial involves the use of Panzyga IVIG as a potential treatment for this condition. In Phase 2 of the study, which became available on 8/1/2023, researchers are exploring the efficacy and safety of this intravenous immunoglobulin therapy. Additionally, Fycompa is being investigated in a Phase 2 trial (available since 1/1/2016) as another possible therapeutic option for small fiber neuropathy. These trials hold promise for improving our understanding and management of this complex neurological disorder.

What small fiber neuropathy clinical trials were recently completed?

One notable recent development in the field of small fiber neuropathy is the completion of a clinical trial investigating Nicotinamide riboside as a potential treatment. Sponsored by Johns Hopkins University, this trial concluded in September 2020. The findings from this study hold significant promise for individuals affected by small fiber neuropathy and provide valuable insights into potential therapeutic options moving forward.